ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,664,183 | -26.0% | 495,489 | -4.2% | 0.00% | 0.0% |
| Q2 2023 | $23,857,282 | +66.0% | 517,175 | +44.3% | 0.00% | 0.0% |
| Q1 2023 | $14,372,242 | +0.6% | 358,410 | +16.2% | 0.00% | 0.0% |
| Q4 2022 | $14,285,716 | -13.8% | 308,347 | -22.9% | 0.00% | 0.0% |
| Q3 2022 | $16,568,000 | -15.8% | 400,113 | +21.4% | 0.00% | -33.3% |
| Q2 2022 | $19,666,000 | +10.7% | 329,649 | +34.7% | 0.00% | +50.0% |
| Q1 2022 | $17,773,000 | +10.1% | 244,739 | +27.5% | 0.00% | 0.0% |
| Q4 2021 | $16,146,000 | -21.8% | 192,004 | -16.2% | 0.00% | -33.3% |
| Q3 2021 | $20,659,000 | -44.5% | 229,069 | -41.3% | 0.00% | -40.0% |
| Q2 2021 | $37,197,000 | +37.7% | 390,098 | +64.5% | 0.01% | +25.0% |
| Q1 2021 | $27,006,000 | -22.4% | 237,182 | -5.6% | 0.00% | -20.0% |
| Q4 2020 | $34,791,000 | +248.5% | 251,328 | +106.9% | 0.01% | +150.0% |
| Q3 2020 | $9,984,000 | +35.3% | 121,473 | +28.8% | 0.00% | 0.0% |
| Q2 2020 | $7,377,000 | +105.9% | 94,303 | +17.0% | 0.00% | +100.0% |
| Q1 2020 | $3,582,000 | -46.4% | 80,615 | -48.5% | 0.00% | -50.0% |
| Q4 2019 | $6,684,000 | +11.9% | 156,510 | +12.1% | 0.00% | 0.0% |
| Q3 2019 | $5,973,000 | +11.7% | 139,660 | +65.9% | 0.00% | +100.0% |
| Q2 2019 | $5,345,000 | +240.7% | 84,168 | +272.1% | 0.00% | – |
| Q1 2019 | $1,569,000 | -75.5% | 22,619 | -84.6% | 0.00% | -100.0% |
| Q4 2018 | $6,402,000 | -44.5% | 147,238 | -2.6% | 0.00% | -33.3% |
| Q3 2018 | $11,541,000 | -19.0% | 151,188 | -18.5% | 0.00% | -25.0% |
| Q2 2018 | $14,255,000 | +139.7% | 185,435 | +59.0% | 0.00% | +100.0% |
| Q1 2018 | $5,947,000 | +35.5% | 116,623 | +23.2% | 0.00% | +100.0% |
| Q4 2017 | $4,389,000 | -0.4% | 94,639 | +14.4% | 0.00% | 0.0% |
| Q3 2017 | $4,408,000 | +6.6% | 82,749 | +24.2% | 0.00% | 0.0% |
| Q2 2017 | $4,137,000 | -59.9% | 66,621 | -56.2% | 0.00% | -50.0% |
| Q1 2017 | $10,318,000 | -46.1% | 152,216 | -44.1% | 0.00% | -33.3% |
| Q4 2016 | $19,132,000 | +440.3% | 272,120 | +445.0% | 0.00% | +200.0% |
| Q3 2016 | $3,541,000 | +121.6% | 49,933 | +52.9% | 0.00% | 0.0% |
| Q2 2016 | $1,598,000 | -13.5% | 32,661 | +11.9% | 0.00% | 0.0% |
| Q1 2016 | $1,848,000 | -46.3% | 29,192 | -4.9% | 0.00% | 0.0% |
| Q4 2015 | $3,441,000 | -4.7% | 30,681 | -18.1% | 0.00% | 0.0% |
| Q3 2015 | $3,609,000 | -34.4% | 37,475 | -30.3% | 0.00% | -50.0% |
| Q2 2015 | $5,505,000 | +24.9% | 53,764 | -24.3% | 0.00% | 0.0% |
| Q1 2015 | $4,408,000 | +49.6% | 70,992 | +5.7% | 0.00% | +100.0% |
| Q4 2014 | $2,947,000 | -24.9% | 67,161 | -3.2% | 0.00% | -50.0% |
| Q3 2014 | $3,926,000 | +98.1% | 69,380 | +57.1% | 0.00% | +100.0% |
| Q2 2014 | $1,982,000 | -50.6% | 44,154 | -46.2% | 0.00% | -50.0% |
| Q1 2014 | $4,014,000 | – | 82,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |